SPC325
Andexanet Alfa
Status:
VeittApplication date:
22.12.2020Application published:
15.1.2021Grant published:
15.11.2022
Max expiry date:
25.9.2033Medicine name:
OndexxyaMedicine for children:
No
Timeline
Today
22.12.2020Application
15.1.2021Publication
15.11.2022Registration
25.9.2033Expires
Marketing license
IS authorization number:
EU/1/18/1345/001Date:
14.6.2019
Foreign authorization number:
EU/1/18/1345Date:
26.4.2019
Owner
Name:
Alexion Pharmaceuticals, Inc.Address:
121 Seaport Boulevard, Boston, MA US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3078743